Kamada Pharmaceuticals (KMDA) - Financial and Strategic SWOT Analysis Review

May 2021 | 52 pages | ID: K2CD78E7ED9EN
GlobalData

Abstracts

Kamada Pharmaceuticals (KMDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kamada Pharmaceuticals (Kamada) is a biopharmaceutical company that develops, manufactures, and markets specialty proteins, specific immunoglobulins and other prescription medicines. Its major products include respiratory, immunoglobins, critical care and other. It also offers medicines for the treatment of cystic fibrosis, asthma, hemophilia, rabies, hepatitis B, and other indications. Kamada's pipeline products include intravenous and inhaled AAT protein and rabies. Its intravenous formulations are intended for Graft vs Host Disease (GVHD), type-1 diabetes, covid-19 and lung transplantation indications. The company distributes its products through a network of distributors in Brazil, Israel, Russia, India and other countries in Eastern Europe, Latin America and Asia regions. Kamada is headquartered in Rehovot, Israel.

Kamada Pharmaceuticals Key Recent Developments

May 12,2021: Kamada Reports First Quarter 2021 Financial Results, Recent Achievements and Corporate Development Activities
May 05,2021: Kamada to Announce First Quarter Ended March 31, 2021 Financial Results and Host Conference Call on May 12, 2021
Apr 20,2021: Israel's Kamada forges ahead with development of new anti-Covid immunoglobulin therapy in partnership with Kedrion Biopharma of Italy
Feb 24,2021: Kamada Files Annual Report for the Year Ended December 31, 2020
Feb 03,2021: Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2020 Financial Results, and Host Conference Call on February 10, 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Kamada Pharmaceuticals - Key Facts
Kamada Pharmaceuticals - Key Employees
Kamada Pharmaceuticals - Key Employee Biographies
Kamada Pharmaceuticals - Major Products and Services
Kamada Pharmaceuticals - History
Kamada Pharmaceuticals - Company Statement
Kamada Pharmaceuticals - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Kamada Pharmaceuticals - Business Description
Business Segment: Distribution
Overview
Performance
Business Segment: Proprietary Products
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Israel
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: Others
Performance
Geographical Segment: The US
Performance
R&D Overview
Kamada Pharmaceuticals - SWOT Analysis
SWOT Analysis - Overview
Kamada Pharmaceuticals - Strengths
Kamada Pharmaceuticals - Weaknesses
Kamada Pharmaceuticals - Opportunities
Kamada Pharmaceuticals - Threats
Kamada Pharmaceuticals - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Kamada Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Kamada Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Kamada Pharmaceuticals, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 12, 2021: Kamada Reports First Quarter 2021 Financial Results, Recent Achievements and Corporate Development Activities
May 05, 2021: Kamada to Announce First Quarter Ended March 31, 2021 Financial Results and Host Conference Call on May 12, 2021
Apr 20, 2021: Israel's Kamada forges ahead with development of new anti-Covid immunoglobulin therapy in partnership with Kedrion Biopharma of Italy
Feb 24, 2021: Kamada Files Annual Report for the Year Ended December 31, 2020
Feb 03, 2021: Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2020 Financial Results, and Host Conference Call on February 10, 2021
Jan 05, 2021: Kamada selected as a winner of the Genesis Prize Foundation and Start-Up Nation Central competition
Nov 11, 2020: Kamada reports third quarter and first nine months of 2020 financial results, recent achievements and corporate development
Aug 25, 2020: Leading biotech companies Kedrion Biopharma of Italy and Kamada of Israel continue their collaboration to develop a new Anti-COVID plasma-based treatment
Aug 12, 2020: Kamada reports second quarter and first six months of 2020 financial results, Recent corporate achievements and strong cash position
Aug 12, 2020: Kamada announces changes to its board of directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Kamada Pharmaceuticals, Key Facts
Kamada Pharmaceuticals, Key Employees
Kamada Pharmaceuticals, Key Employee Biographies
Kamada Pharmaceuticals, Major Products and Services
Kamada Pharmaceuticals, History
Kamada Pharmaceuticals, Other Locations
Kamada Pharmaceuticals, Subsidiaries
Kamada Pharmaceuticals, Key Competitors
Kamada Pharmaceuticals, Ratios based on current share price
Kamada Pharmaceuticals, Annual Ratios
Kamada Pharmaceuticals, Annual Ratios (Cont...1)
Kamada Pharmaceuticals, Annual Ratios (Cont...2)
Kamada Pharmaceuticals, Interim Ratios
Kamada Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Kamada Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Kamada Pharmaceuticals, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Kamada Pharmaceuticals, Performance Chart (2016 - 2020)
Kamada Pharmaceuticals, Ratio Charts
Kamada Pharmaceuticals, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Kamada Pharmaceuticals, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021